title: Bevacizumab in adult malignant brainstem gliomas.
authors.affiliation: Department of Neuro-Oncology, New York University Langone Medical Center, New York, NY, 10016, USA. shahzad.raza@nyumc.org.|Department of Radiation Oncology, New York University Langone Medical Center, New York, NY, 10016, USA. shahzad.raza@nyumc.org.
authors.forename: Shahzad
authors.initials: S
authors.lastname: Raza
authors.affiliation: Department of Radiation Oncology, New York University Langone Medical Center, New York, NY, 10016, USA.
authors.forename: Martin
authors.initials: M
authors.lastname: Donach
mesh_terms: D000328:Adult; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D020295:Brain Stem Neoplasms / Q000098:blood supply / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D016896:Treatment Outcome; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors* / Q000276:immunology / Q000378:metabolism
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab